page_banner

Products

(4R-CIS)-1,1-DIMETHYLETHYL-6-[2-[2-(4-FLUOROPHENYL) -5-(1-METHYLETHYL)-3-PHENYL-IV-[(PHENYLAMINO) CARBONYL. -1-yl]ETHYL]-2,2-DIMETHYL-1,3-DIOXANE-4-ACETATE CAS: 125971-95-1

Description:

Catalogue Number: XD93348
Cas: 125971-95-1
Formulae hypotheticae: C40H47FN2O5
Pondus hypotheticum: 654.81
Availability: In Stock
Pretium:  
Prepack:  
Mole Pack: Request Quote

 


Product Detail

Product Tags

Catalogue Number XD93348
Product Name (4R-CIS)-1,1-DIMETHYLETHYL-6-[2-[2-(4-FLUOROPHENYL) -5-(1-METHYLETHYL)-3-PHENYL-IV-[(PHENYLAMINO) CARBONYL. -1-yl]ETHYL]-2,2-DIMETHYL-1,3-DIOXANE-4-ACETATE
CAS 125971-95-1
Formulae hypotheticaela C40H47FN2O5
M. Pondus 654.81
Repono Details Ambiens

 

Product Specification

Aspectus Pulvis albus
Assay 99% min

 

(4R-Cis)-1,1-Dimethylethyl-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol. -1-yl]ethyl]-2,2-dimethyl-1,3-dioxanum-4-acetatum compositum est cum structura chemica complexa.Dum certae informationes de usibus huius compositi limitari possunt, discutere possumus eius applicationes potentiales in structuris suis notis et communibus notis similium compositorum. Praesentia medietatis dioxanae in hac compositione suggerit ut possessiones solvendas habeat vel adhiberi possit. ut a agente solubilizing.Dioxane est communis solvens, praesertim in chemia organica, sicut aquatica miscibilis est et bonam habet solubilitatem pro moleculis organicis amplis.Praesentia medietatis dioxanae in hac compositione indicat ut similes solubilitates possessiones possideret. Praeterea membra structurae huius compositi, ut fluorophenyl et phenylamini carbonyl coetus, potentialem actionem biologicam suggerunt.Fluorine substitutio in compositis organicis proprietatibus pharmacokineticis augere potest, potentia augere suam potentiam vel bioavailability.Praesentia globi phenylamini carbonyl potentiam demonstrare potest ad commercium cum scutis biologicis, fortasse ad therapeuticos effectus. Ex his formis structuralibus, fieri potest ut haec compositio applicationes in chemia medicinali vel medicamento evolutionis habere possit.Potens explorari potest ut plumbum compositum potentiale ad progressionem novorum medicamentorum morbis specificis targeting.Attamen interest notare ulteriora studia opus esse ad proprietates pharmacologicas actuales determinare, inclusas efficaciam, mechanismum actionis et effectus potentiales. Praeter medicinalem chemiam, haec compositio nitronyl vel pyrrolis medietas applicationes in scientia materiae suggerere potuit. aut sicut pars in chemicis synthesin.Derivationes nitronyl et pyrrolae exploratae sunt pro usu potentiale ut conductores organici, catalysts, vel caudices structurarum multipliciorum aedificationum.Attamen huiusmodi applicationes ulteriorem inquisitionem et optimizationem syntheseos methodorum requirent. Super composita (4R-Cis)-1,1-Dimethylethyl-6-[2-[2-(4-fluorophenyl) -5-(1- methylethyl) -3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate. materiarum scientia, seu synthesis chemica.Attamen magnae investigationis est perpendere suas proprietates aestimare, congruere itinera enucleare, propriasque applicationes in unoquoque campo determinare.


  • Priora:
  • Deinde:

  • Close

    (4R-CIS)-1,1-DIMETHYLETHYL-6-[2-[2-(4-FLUOROPHENYL) -5-(1-METHYLETHYL)-3-PHENYL-IV-[(PHENYLAMINO) CARBONYL. -1-yl]ETHYL]-2,2-DIMETHYL-1,3-DIOXANE-4-ACETATE CAS: 125971-95-1